Thomas J Lobl - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 27, 2019

DermaPort: A Novel Ported Vascular Access System for HemodialysisThomas J Lobl, Abram D Janis, Buzz Moran

Cardiovascular and Interventional Radiology|July 15, 2018

A Prospective Clinical Study of a Percutaneous Vascular Access System for Hemodialysis CathetersDheeraj K Rajan, Buzz Moran, Thomas J Lobl, et al.

Antimicrobial Agents and Chemotherapy|April 18, 2002

NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strainsQing Li, Jean Y Lee, Rosario Castillo, et al.

Cancer Research|April 17, 2002

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivityVincent Dubois, Luc Dasnois, Karim Lebtahi, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 27, 2019

DermaPort: A Novel Ported Vascular Access System for HemodialysisThomas J Lobl, Abram D Janis, Buzz Moran

Cardiovascular and Interventional Radiology|July 15, 2018

A Prospective Clinical Study of a Percutaneous Vascular Access System for Hemodialysis CathetersDheeraj K Rajan, Buzz Moran, Thomas J Lobl, et al.

Antimicrobial Agents and Chemotherapy|April 18, 2002

NB2001, a novel antibacterial agent with broad-spectrum activity and enhanced potency against beta-lactamase-producing strainsQing Li, Jean Y Lee, Rosario Castillo, et al.

Cancer Research|April 17, 2002

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivityVincent Dubois, Luc Dasnois, Karim Lebtahi, et al.

Pageof 1